Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.76 USD | +1.26% | +4.02% | -14.38% |
May. 01 | TD Cowen Adjusts Price Target on Incyte to $80 From $88 | MT |
May. 01 | RBC Capital Adjusts Price Target on Incyte to $60 From $65 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.38% | 12.07B | |
-3.72% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-5.38% | 8.5B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Transcript : Escient Pharmaceuticals, Inc., Incyte Corporation - M&A Call